Several studies found that the expression of TP53 in cancer tissues of ESCC patients could be utilized to analyze the survival and prognosis of esophageal cancer (Yao et al., 2014; Xie et al., 2017; Melling et al., 2019). This evidence concerns the gene TP53 and cancer.